Organogenesis Holdings Inc
ORGO
NASDAQ
Biotechnology
$1.79
USD
+0.03 (+1.70%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $230.97M
Volume 547.6K
Price Target
$3.00 – $3.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $3.00 and a min estimate of $3.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$3.00
-$5.0 vs prior
Implied Upside
+67.6%
-279.3% vs prior
Analyst Covering
1
Unchanged vs prior period
Consensus
Hold
Declined vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Hold
0 Buy
1 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Ravi Misra | Truist Securities | Hold | Initiated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
AKBA
Akebia Therapeutics Inc
$0.8700
▲ +0.4%
ARCT
Arcturus Therapeutics Holdings Inc
$8.23
▲ +4.7%
CNXU
Conexeu Sciences Inc
$8.90
▲ +11.7%
TARA
Protara Therapeutics Inc
$3.97
▲ +0.8%
NERV
Minerva Neurosciences Inc
$4.58
▲ +16.8%
ALEC
Alector Inc
$1.96
▼ -3.9%
NBP
NovaBridge Biosciences
$1.96
▲ +3.2%
RNA
Atrium Therapeutics Inc
$12.84
▲ +4.1%
IMUX
Immunic Inc
$16.06
▼ -3.1%